Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €21.94 EUR
Change Today -0.382 / -1.71%
Volume 365.1K
QIA On Other Exchanges
Symbol
Exchange
Xetra
NASDAQ GS
As of 12:06 PM 06/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Roland Sackers

Chief Financial Officer and Managing Director, Qiagen NV
AgeTotal Calculated CompensationThis person is connected to 12 board members in 3 different organizations across 5 different industries.

See Board Relationships
46$945,000
As of Fiscal Year 2014

Background*

Mr. Roland Sackers has been the Chief Financial Officer of Qiagen NV since January 1, 2004 and has been its Managing Director since 2006. Mr. Sackers served as a Vice President of Finance at Qiagen NV from 1999 to 2004 and served as its Deputy Managing Director from January 1, 2004 to 2006. He has been a Non-Executive Director for Immunodiagnostic Systems Holdings plc since June 1, 2011 and also serves as its Senior Independent non-executive Director. He serves as a ...

Read Full Background

Corporate Headquarters*

Spoorstraat 50
Venlo, Limburg 5911 KJ

Netherlands

Phone: 31 77 320 8400
Fax: 31 77 320 8409

Board Members Memberships*

Director
2011-Present
Senior Independent Non-Executive Director and Chairman of Audit Committee
2011-Present
Director

Education*

MBA 2006
Westfälische Wilhelms-Universität Münster

Other Affiliations*

Annual Compensation*

Salary$601,000
Bonus$210,000
Total Annual Compensation$811,000

Stock Options*

All Other Compensation$134,000
Exercisable Options152,220
Unexercisable Options43,901
Total Number of Options196,121

Total Compensation*

Total Annual Cash Compensation$945,000
Total Short Term Compensation$811,000
Other Long Term Compensation$134,000
Total Calculated Compensation$945,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
QIA:GR €21.94 EUR -0.382

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John L. Bishop Chairman, Chief Executive Officer and Member of Equity Incentive Committee
Cepheid
$664.9K
Peter D. Meldrum Ph.D.Chief Executive Officer, President and Director
Myriad Genetics Inc.
$997.0K
Marc D. Grodman M.D.Founder, Chairman, Chief Executive Officer, President and Managing Director
Bio-Reference Laboratories Inc.
$1.2M
Robert F. Friel Chairman, Chief Executive Officer, President and Member of Finance Committee
PerkinElmer Inc.
$1.0M
Alexandre Merieux Chief Executive Officer, Director and Member of Strategy Committee
bioMérieux SA
€669.5K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QIAGEN N.V., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.